Argenx
ARGX
#413
Rank
NZ$98.10 B
Marketcap
NZ$1,575
Share price
0.92%
Change (1 day)
50.53%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

We have found no dividend yield history for this company